Skip to main content
. 2017 Nov 21;37(6):BSR20170973. doi: 10.1042/BSR20170973

Figure 1. Effect of IL-12 on hPDLFs.

Figure 1

hPDLFs were treated with 0, 5, and 10 ng/ml of IL-12 for 12, 24, and 48 h, and cell viability was assessed by MTT assay. Data are expressed as percentage of cell viability relative to the control (0 ng/ml). Data represented as means ± S.E.M. (n=3).